Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.630
+0.003 (0.21%)
Aug 29, 2025, 11:28 AM EDT
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $78.04 million as of August 29, 2025. Its market cap has increased by 213.87% in one year.
Market Cap
78.04M
Enterprise Value
77.86M
Revenue
1.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.63
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 78.04M, an increase of 293.07%. That is a compound annual growth rate of 17.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 78.04M | 19.07% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | 13.62M | 378.33% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 838.96M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.83M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 396.18M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 376.01M |